SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051476
Filing Date
2020-11-05
Accepted
2020-11-05 17:18:18
Documents
94
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acet-10q_20200930.htm   iXBRL 10-Q 3590572
2 EX-31.1 acet-ex311_9.htm EX-31.1 15616
3 EX-31.2 acet-ex312_6.htm EX-31.2 15832
4 EX-32.1 acet-ex321_7.htm EX-32.1 7728
  Complete submission text file 0001564590-20-051476.txt   12779036

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acet-20200930.xsd EX-101.SCH 85480
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acet-20200930_cal.xml EX-101.CAL 58799
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acet-20200930_def.xml EX-101.DEF 333033
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20200930_lab.xml EX-101.LAB 573662
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20200930_pre.xml EX-101.PRE 477658
10 EXTRACTED XBRL INSTANCE DOCUMENT acet-10q_20200930_htm.xml XML 2637296
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 201291589
SIC: 2834 Pharmaceutical Preparations